Thomas E. Ichim

Biography

Dr. Thomas E. Ichim, also known as Tom, Ph.D. serves as Senior Vice President, Chief Executive Officer of Biotechnology Division and President of Biotechnology Division of Creative Medical Health, Inc. Dr. Ichim has been the Chief Scientific Officer at Creative Medical Technology Holdings, Inc. since March 8, 2017. He serves as Senior Research Consultant at Zander Therapeutics, Inc. He is Founder of Nobilis Therapeutics Inc. Dr. Ichim is a Co-founder of Batu Biologics, Inc. and has been its Chief Scientific Officer since December 21, 2015. He has been President of CMT since February 2016. Dr. Ichim is the founder of ToleroTech Inc., OncoMune LLC and MedVax Pharma Corp. He served as President of the Biotech Division, since October 2011. He served as the President and Chief Scientific Officer at Medistem, Inc., since October 6, 2012 until 2015. Dr. Ichim served as Senior Research Consultant at Regen BioPharma, Inc. since July 2, 2016. He served as a Director of Research and Chief Scientific Officer of Regen BioPharma Inc from June 15, 2012 to October 30, 2015. Dr. Ichim served as the Chief Scientific Officer of bioRASI, LLC. He has 20 years experience in the biotechnology industry, having served as the Vice President of Cellular Therapies and Intrexon, Inc. Dr. Ichim served as the Chief Executive Officer of Medistem, Inc., since March 18, 2008 until October 6, 2012 and served as its Chief of Scientific Development officer since January 2007. He served as Vice-President of Creative Medical Health. He served as an Executive Chairman of Batu Biologics Inc. from January 2014 to 2015. He is a seasoned biotechnology entrepreneur with a track record of scientific excellence. Dr. Ichim served a variety of instrumental roles for companies operating in the area of biologics. He obtained numerous regulatory approvals for companies such as MarrowTech Pharma and served as a Program manager for the global CRO bioRASI from 2004 to 2007, under which he led efforts to develop, clinically assess and approve various stem cell and cellular therapies. He is an accomplished Scientist with 15 scientific papers published in areas ranging from immunological tolerance, to cancer therapy, to autoimmunity. Dr. Ichim serves as a Director of Creative Medical Health, Inc. He has been a Director of Creative Medical Technology Holdings, Inc. since February 2016. He serves as a Member of Advisory Board at Cromos Pharma,LLC. He serves as a Member of the Scientific Advisory Board at Orcrist Bio Inc., Entest and MBVax Bioscience Inc. He is an ad-hoc editor and sits on several editorial boards. He has co-authored many scientific journal articles and is a peer reviewer for several scientific journals in the area of immunology and translational medicine. He is a member of Vendevia Group. He has been a Director of CMT since February 2016. He has been a Director of Therapeutic Solutions International, Inc. since January 22, 2016. He served as Director at Regen BioPharma Inc from July 15, 2013 to October 30, 2015. He served as a Director at Medistem, Inc. from 2007 to 2015. Dr. Ichim has written over 100 peer reviewed publications and has founded and operated successful biotech companies in the past. Dr. Ichim attended the University of Waterloo for his undergraduate training and graduate school at the University of Western Ontario, Canada. He is inventor of 37 patents and patent applications. He holds a BSc in Biology from University of Waterloo, Waterloo, Ontario, Canada in 1998 and an MSc in Microbiology and Immunology from University of Western Ontario, London, Ontario, Canada in 2003. He also holds a Ph.D in Immunology from University of Sciences Arts and Technology, Olveston Monserrat in 2007.

Research Interest

 Mother and Child Health